Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OTLKW - Outlook Therapeutics Inc - Warrants - Series A (18/02/2022)

Previous close
0.03
0   0%

Share volume: 0
Last Updated: Wed 16 Feb 2022 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing : -3.41%

PREVIOUS CLOSE
CHG
CHG%
$0.03
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
76%
Profitability 93%
Dept financing 25%
Liquidity 0%
Performance 90%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.03
P/E Ratio 
0.00
DAY RANGE
$0.03 - $0.03
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
376.784 M
YIELD 
N/A
SHARES OUTSTANDING 
2.917 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Lawrence Kenyon
Region: US
Website: https://outlooktherapeutics.com/
Employees: 8
IPO year: -
Issue type:
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

Recent news